Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-Chain bridges

2002 ◽  
Vol 12 (18) ◽  
pp. 2627-2633 ◽  
Author(s):  
Panagiota Roumelioti ◽  
Ludmila Polevaya ◽  
Panagiotis Zoumpoulakis ◽  
Nektarios Giatas ◽  
Ilze Mutule ◽  
...  
2005 ◽  
Vol 15 (9) ◽  
pp. 2243-2247 ◽  
Author(s):  
Ian Paterson ◽  
Dirk Menche ◽  
Anders E. Håkansson ◽  
Adrian Longstaff ◽  
David Wong ◽  
...  

2010 ◽  
Vol 82 (1) ◽  
pp. 339-347
Author(s):  
Fei Yu ◽  
Ruifang Pang ◽  
Dekai Yuan ◽  
Meizi He ◽  
Chunlei Zhang ◽  
...  

A novel series of compounds, derived from [1,2,3]triazolo[4,5-d]pyrimidines with a guanidyl group or amino group-terminated side chain was designed and synthesized as HIV-1 trans-activator of transcription–trans-activation responsive region (Tat–TAR) interaction inhibitors. Their ability to inhibit Tat–TAR RNA interaction was determined by a Tat-dependent HIV-1 long terminal repeat (LTR)-driven chloramphenicol acetyltransferase (CAT) assay and simian immunodeficiency virus (SIV)-induced syncytium evaluation. The binding of the compounds with TAR RNA was conducted by molecular modeling and capillary electrophoresis (CE) analysis. The results showed that all the compounds could block the Tat–TAR interaction and have antiviral activities.


Sign in / Sign up

Export Citation Format

Share Document